Financhill
Back

Guardant Health Quote, Financials, Valuation and Earnings

Guardant Health Price Quote

$30.29
-1.32 (-4.18%)
(Updated: November 14, 2024 at 5:20 PM ET)

Guardant Health Key Stats

Buy
91
Guardant Health (GH) is a Buy

Day range:
$29.52 - $32.26
52-week range:
$15.81 - $37.04
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.22
P/B ratio:
0%

Volume:
2.9M
Avg. volume:
1.8M
1-year change:
39.68%
Market cap:
$3.7B
Revenue:
$563.9M
EPS:
$-4.24

How Much Does Guardant Health Make?

Is Guardant Health Growing As A Company?

  • What Is Guardant Health's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.34%
  • What Is Guardant Health's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Guardant Health Stock Price Performance

  • Did Guardant Health Stock Go Up Last Month?
    Guardant Health share price went up by 47.71% last month
  • Did GH's Share Price Rise Over The Last Year?
    GH share price rose by 39.68% over the past 1 year

What Is Guardant Health 52-Week High & Low?

Guardant Health Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Guardant Health?

  • How Much Debt Does Guardant Health Have?
    Total long term debt quarterly is $1.1B
  • How Much Cash Does Guardant Health Have?
    Cash and short term investments quarterly total is $999.1M
  • What Is Guardant Health’s Book Value Per Share?
    Book value per share is -0.49

Is Guardant Health Cash Flow Positive?

  • What Is GH Cash Flow From Operations?
    Cash flow from operations (TTM) is -$254.1M
  • What Is Guardant Health’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $92.5M
  • What Is Guardant Health’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $391.6M

Guardant Health Return On Invested Capital

  • Is Management Doing A Good Job?
    GH return on invested capital is -42.02%
  • What Is Guardant Health Return On Assets?
    ROA measures how assets are converting to revenues and is -30.37%
  • What Is GH Return On Equity?
    ROE is a measure of profitability and is -651%

Guardant Health Earnings Date & Stock Price

Guardant Health Competitors

  • Who Are Guardant Health's Competitors?
    Below is a list of companies who compete with Guardant Health or are related in some way:
    • CytoSorbents Corp (CTSO)
    • Delcath Systems Inc (DCTH)
    • Exact Sciences Corp (EXAS)
    • Progyny Inc (PGNY)
    • Star Equity Holdings Inc (STRR)

Guardant Health Dividend Yield

Guardant Health Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 24.38%
Revenue: 33.87% 12.25%

Analyst Recommendations

Buy Recommendations: 14
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 43.00
Upside from Last Price: 36.03%

Major Shareholders

  • How many GH shares are owned by institutional investors?
    186.1M GH shares are owned by institutional investors
  • How many GH shares are owned by insiders?
    5M GH shares are owned by insiders